2021 American Transplant Congress
Optimal Antimicrobial Duration for Donor Positive Cultures in Kidney Transplant Recipients
Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Utilization of organs from infected donors carries the risk of transmission of the donor organism to the recipient. While antimicrobials are recommended in recipients…2021 American Transplant Congress
Epidemiology and Risk Factors for Invasive Fungal Infection in Pancreas Transplant in the Absence of Fungal Prophylaxis
*Purpose: Invasive fungal infections (IFI) remain a rare yet dreaded complication following pancreas transplantation. Current guidelines recommend antifungal prophylaxis in patients with 1 or more…2021 American Transplant Congress
The Role of Pre-transplant Rectal Screening for Azole-resistant Candida Species in Liver Transplant Candidates
*Purpose: Azole-resistant Candida (ARC) infections have become increasingly common among solid organ transplant recipients. Pre-transplant screening for ARC allows for targeted antifungal prophylaxis, which may…2021 American Transplant Congress
Cryptococcosis in Renal Transplant Recipients —An Analysis of United States Renal Data System Data
Montefiore Medical Center, Bronx, NY
*Purpose: Solid organ transplant recipients are at increased risk for cryptococcosis, which is known to decrease their survival. Adherence to recommended management strategies and outcomes…2021 American Transplant Congress
Clinical Characteristics and Outcomes of Aspergillus Infections in Intestinal Transplant Patients: Retrospective Cohort Study
Miami Transplant Institute, Jackson Health System, Miami, FL
*Purpose: Aspergillus infection is the most common mold infection in solid organ transplant recipients and its consequences can be fatal. Data in intestinal transplants (ITx)…2021 American Transplant Congress
Utilizing Risk Factors to Guide Prevention of Invasive Fungal Infections in Liver Transplant Recipients
University of Utah Health, Salt Lake City, UT
*Purpose: Invasive fungal infection (IFI) after liver transplant (LT) is associated with significant morbidity and mortality. The optimal antifungal prophylaxis regimen has not been defined.…2021 American Transplant Congress
Perioperative Anidulafungin Combined with Triazole Prophylaxis for the Prevention of Early Invasive Candidiasis in Lung Transplant Recipients
*Purpose: Invasive candidiasis (IC) is a substantial cause of morbidity and mortality in lung transplant recipients (LTRs). Post-operative factors, such as prolonged hospital stay, central…2021 American Transplant Congress
Incidence of Oral Candidiasis in Renal and/or Pancreas Transplant Recipients When Administering Prophylaxis versus No Prophylaxis
*Purpose: Oropharyngeal candidiasis (OC), or thrush, is a fungal infection associated with immunosuppression post renal and or/pancreas transplant. Currently, the role of prophylactic oral nystatin…2021 American Transplant Congress
Evaluation of Fungal Prophylaxis Post-Lung Transplantation
1Temple University Hospital, Philadelphia, PA, 2Temple School of Pharmacy, Philadelphia, PA
*Purpose: Fungal infections are responsible for approximately 15-35% of all infections in lung transplant recipients; 80% of which are due to aspergillus or candida. At…2021 American Transplant Congress
Characterization of SGLT2 Inhibitor Use After Abdominal Transplant
*Purpose: Post solid organ transplantation, diabetic kidney disease (DKD) can progress due to recurrent pre-transplantation diabetes or the development of post-transplantation diabetes mellitus (PTDM). This…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 10
- Next Page »